carvedilol has been researched along with Cirrhoses, Experimental Liver in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol treatment did not affect serum biochemistry in either sham-operated or cirrhotic rats." | 1.33 | Hemodynamic effects of one week of carvedilol administration on cirrhotic rats. ( Hou, MC; Huang, YT; Lee, SD; Lee, TY; Lin, HC; Wang, YW; Wei, HC; Yang, YY, 2006) |
| "Carvedilol was highly bound to plasma proteins; binding was reduced by pcs." | 1.29 | Rats with portacaval shunt as a potential experimental pharmacokinetic model for liver cirrhosis: application to carvedilol stereopharmacokinetics. ( Baumgartner, U; Henke, D; Mutschler, E; Schölmerich, J; Spahn-Langguth, H; Stahl, E, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Kawy, HS | 1 |
| Rodríguez, S | 1 |
| Raurell, I | 1 |
| Ezkurdia, N | 1 |
| Augustin, S | 1 |
| Esteban, R | 1 |
| Genescà, J | 1 |
| Martell, M | 1 |
| Lin, HC | 1 |
| Huang, YT | 1 |
| Wei, HC | 1 |
| Yang, YY | 1 |
| Lee, TY | 1 |
| Wang, YW | 1 |
| Hou, MC | 1 |
| Lee, SD | 1 |
| Stahl, E | 1 |
| Baumgartner, U | 1 |
| Henke, D | 1 |
| Schölmerich, J | 1 |
| Mutschler, E | 1 |
| Spahn-Langguth, H | 1 |
4 other studies available for carvedilol and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferas | 2021 |
The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats.
Topics: Adrenergic beta-Antagonists; Animals; Atorvastatin; Bilirubin; Carbazoles; Carvedilol; Creatinine; D | 2015 |
Hemodynamic effects of one week of carvedilol administration on cirrhotic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Animals; Biomarkers; Carbazoles; Carvedil | 2006 |
Rats with portacaval shunt as a potential experimental pharmacokinetic model for liver cirrhosis: application to carvedilol stereopharmacokinetics.
Topics: Adrenergic beta-Antagonists; Animals; Bile; Blood Proteins; Carbazoles; Carvedilol; Kidney; Liver; L | 1993 |